SCHACHLE JOSEPH K 4
4 · Opus Genetics, Inc. · Filed Jul 27, 2026
Research Summary
AI-generated summary of this filing
Opus Genetics (IRD) COO Joseph Schachle Sells Shares
What Happened
Joseph K. Schachle, Chief Operating Officer of Opus Genetics (IRD), disposed of 4,644 shares on July 23, 2026 at $2.94 per share, generating $13,653 in proceeds. The sale was executed automatically to satisfy tax withholding obligations related to a restricted stock unit (RSU) vesting and settlement—this was not a discretionary trade by the reporting person.
Key Details
- Transaction date and price: 2026-07-23, sale at $2.94 per share
- Shares sold / proceeds: 4,644 shares; $13,653 total
- Shares owned after transaction: Not specified in the provided filing
- Footnote: Sale was automatic to cover tax withholding from an RSU vest/settlement (not a voluntary sale)
- Filing date / timeliness: Form filed 2026-07-27 — within the SEC’s two-business-day reporting window for Form 4
Context
This was a tax-withholding disposition tied to an equity award settlement (RSUs). Such automatic sales are common and do not necessarily reflect the insider’s market view; they are administrative transactions to satisfy tax obligations rather than discretionary selling.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-07-23$2.94/sh−4,644$13,653→ 291,440 total
Footnotes (1)
- [F1]The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.